| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |